^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TQB2103

    i
    Other names: TQB2103, TQB-2103, TQB 2103
    Associations
    News
    Trials
    Company:
    Sino Biopharm
    Drug class:
    Topoisomerase I inhibitor, CLDN18.2-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials